周一，Esperion Therapeutics的股价上涨幅度高达23%。这是该公司约一年来最大的盘中涨幅，此次涨势紧随公司宣布向加拿大卫生部提交两种降胆固醇治疗药物Nexletol和Nexlizet的新药申请（NDSs）之后。

Wall Street expects Bitcoin miner CleanSpark Inc (NASDAQ:CLSK) to report a loss of 18 cents per share and $88.65 million in ...

Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its target price reduced by BTIG Research from $50.00 to $9.00 in a ...

TD Securities assumed coverage on shares of Endeavour Silver (NYSE:EXK – Free Report) (TSE:EDR) in a research report report ...

Riding on Bitcoin’s surge and Iris Energy’s operational advancements, analysts have revised their price targets for Iris ...

To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

Fintel reports that on November 26, 2024, HC Wainwright & Co. downgraded their outlook for Cassava Sciences (NasdaqCM:SAVA) ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

2024年11月23日，**比特数字（BTBT）**在盘中上涨了2.13%，最新成交价为4.075美元每股，成交额达到3098.78万美元。这一价格波动突显出投资者对比特数字未来发展的兴趣，尤其是在公司最近发布的财务数据和分析师评级的背景下显得尤为重要。

11月23日，比特数字 (BTBT)盘中上涨10.09%，截至03:50，报4.393美元/股，成交6984.64万美元。 财务数据显示，截至2024年09月30日，比特数字收入总额8194.65万美元，同比增长183.92%；归母净利润-66.67万美元，同比增长94.38%。

HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral therapies for immune-mediated diseases. Alumis’ lead drug candidate, ...